The stock rose more than 20 per cent in a week and over 40 per cent in the last 3 months. The stock is trading around overbought levels. Hence, some consolidation cannot be ruled out. The relative strength index (RSI) is at 84. RSI above 80 is considered strongly overbought. This implies that stock may show pullback, Trendlyne data showed. MACD is above its center and signal line, this is a bullish indicator.
Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?
Despite a challenging market backdrop fueled by geopolitical tensions and foreign fund outflows, five Indian sectors—Pharma, Energy, Defence, Capital Markets, and Metals—are showing remarkable strength.
May 25, 2026